BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2577706)

  • 1. Prolonged infusion of varied doses of dopexamine hydrochloride for circulatory failure after cardiac surgery.
    Santman FW; Thomas SM; Hoskins B
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):13. PubMed ID: 2577706
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolonged infusion of varied doses of dopexamine hydrochloride for low cardiac output after cardiac surgery.
    Santman FW
    J Cardiothorac Vasc Anesth; 1992 Oct; 6(5):568-72. PubMed ID: 1358247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of dopexamine hydrochloride in patients with low cardiac output after cardiac surgery.
    Du Gres B; Flamens C; Gruner MC
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):16. PubMed ID: 2577709
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemodynamic effects of dopexamine hydrochloride administered by an intracoronary infusion technique.
    Demeyere R; Flameng W; Lunkenheimer P
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):15. PubMed ID: 2577708
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopexamine hydrochloride: pharmacology and use in low cardiac output states.
    Ghosh S; Gray B; Oduro A; Latimer RD
    J Cardiothorac Vasc Anesth; 1991 Aug; 5(4):382-9. PubMed ID: 1678660
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of dopexamine after cardiac surgery: acute and long-term effects in patients with impaired cardiac function.
    Friedel N; Wenzel R; Matheis G; Hetzer R
    Thorac Cardiovasc Surg; 1992 Dec; 40(6):378-81. PubMed ID: 1363257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of dopexamine in patients following coronary artery bypass surgery.
    Poelaert JI; Mungroop HE; Koolen JJ; Van den Berg PC
    J Cardiothorac Anesth; 1989 Aug; 3(4):441-3. PubMed ID: 2577703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopexamine hydrochloride, a novel drug with renal vasodilator properties: two case studies.
    Bodenham AR; Park GR
    Intensive Care Med; 1988; 14(6):663-5. PubMed ID: 3183194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral vascular effects of dopexamine hydrochloride during cardiopulmonary bypass.
    Siemons AW; van der Starre PJ
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):14. PubMed ID: 2577707
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemodynamic effects of different doses of dopexamine hydrochloride in low cardiac output states following cardiac surgery.
    Friedel N; Wenzel R; Matheis G; Kuppe H; Bittner H; Filcek S; Hetzer R
    Eur Heart J; 1992 Sep; 13(9):1271-6. PubMed ID: 1356772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of a short-term (6-h) intravenous infusion of dopexamine in patients with severe congestive heart failure: a randomized, double-blind, parallel, placebo-controlled multicenter study.
    Gollub SB; Elkayam U; Young JB; Miller LW; Haffey KA
    J Am Coll Cardiol; 1991 Aug; 18(2):383-90. PubMed ID: 1677368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dopexamine: a new catecholamine used in the treatment of low cardiac output after heart surgery].
    Du Grès B; Flamens C
    Ann Fr Anesth Reanim; 1991; 10(1):21-7. PubMed ID: 1672583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic and renal effects of dopexamine after cardiac surgery in children.
    Habre W; Beghetti M; Roduit C; Girardin E; Vallotton M; Friedli B; Berner M
    Anaesth Intensive Care; 1996 Aug; 24(4):435-9. PubMed ID: 8862639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the efficacy of dopexamine and dobutamine for increasing oxygen delivery in high-risk surgical patients.
    Boyd O; Lamb G; Mackay CJ; Grounds RM; Bennett ED
    Anaesth Intensive Care; 1995 Aug; 23(4):478-84. PubMed ID: 7485941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of dopexamine HCl in conscious and halothane-anaesthetised horses.
    Muir WW
    Equine Vet J Suppl; 1992 Feb; (11):24-9. PubMed ID: 9109955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular pharmacology of dopexamine in low output congestive heart failure.
    Leier CV; Binkley PF; Carpenter J; Randolph PH; Unverferth DV
    Am J Cardiol; 1988 Jul; 62(1):94-9. PubMed ID: 2898209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amrinone versus dopamine and nitroglycerin in neonates after arterial switch operation for transposition of the great arteries.
    Laitinen P; Happonen JM; Sairanen H; Peltola K; Rautiainen P
    J Cardiothorac Vasc Anesth; 1999 Apr; 13(2):186-90. PubMed ID: 10230954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic and muscle oxygen uptake/delivery after dopexamine infusion in endotoxic dogs.
    Bredle DL; Cain SM
    Crit Care Med; 1991 Feb; 19(2):198-204. PubMed ID: 1671210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dopexamine: a new dopaminergic agonist].
    Perrin G; Papazian L; Martin C
    Ann Fr Anesth Reanim; 1993; 12(3):308-20. PubMed ID: 7902685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopexamine hydrochloride. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in acute cardiac insufficiency.
    Fitton A; Benfield P
    Drugs; 1990 Feb; 39(2):308-30. PubMed ID: 1970288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.